Introduction: Nanjing Zhongshan Pharmaceutical Co., Ltd. is a backbone pharmaceutical enterprise under Nanjing Pharmaceutical Industry Group (ranked 295th among China's top 500 enterprises in 2010). It is a demonstration unit for corporate integrity in China, a high-tech enterprise in Jiangsu Province, It is a key intellectual property protection unit in Jiangsu Province and a contract-honoring and trustworthy enterprise by the Nanjing Administration for Industry and Commerce.

The company was founded in 1990 and was originally affiliated to Nanjing General Hospital of Nanjing Military Region. In 1998, it was transferred to the local government and affiliated to Nanjing Pharmaceutical Industry Group Co., Ltd. The company's original factory address is located at No. 1 Shuanglong Street, Yuhuatai District, Nanjing City. It passed GMP certification for the first time in May 2003 and passed GMP re-certification in March 2008.

In 2009, in order to support the construction of the national Beijing-Shanghai high-speed railway, Nanjing Pharmaceutical Industry Group invested 120 million yuan. Taking the opportunity of the relocation and reconstruction of Zhongshan Pharmaceutical Company, it built a new hospital on Hengfa Road, Nanjing Economic and Technological Development Zone. A modern production base of traditional Chinese medicine that focuses on extraction of traditional Chinese medicine and oral dosage forms.

The company's new factory was completed in October 2010. It passed the on-site acceptance of the pharmaceutical GMP certification in early December. In January 2011, it obtained the pharmaceutical GMP certificate and went into production smoothly. The new factory covers an area of ??72 acres, with a construction area of ??20,000 square meters in the first phase, and a production capacity of 1,500 tons of Chinese medicinal materials per year, 1 billion capsules per year, 300 million tablets per year, and 70 million bags of granules per year.

Quality Assurance

The company has advanced production technology and equipment, and has newly introduced Bosch fully automatic capsule machines, jet pulverizers, microwave vacuum dryers, CO2 supercritical extraction devices, and hopper mixing machine, small box automatic packaging line, high-performance liquid chromatograph, gas chromatograph, infrared spectrometer, atomic absorption and many other advanced equipment and inspection instruments; it has a high-quality workforce and strong technical force, with more than 46% of professional and technical personnel ; We have a complete quality assurance system, implement the quality authorized person system in accordance with the requirements of the new version of GMP, and organize production in strict accordance with GMP to ensure the production of high-quality products.

Technological Innovation

The company adheres to the innovation of "combination of technological innovation with digestion and absorption", "combination of technological innovation with secondary development", "combination of technological innovation with intellectual property rights" The strategy focuses on the use of advanced modern technologies such as supercritical fluid extraction technology, ultrafine grinding technology, β-cyclodextrin inclusion technology, etc., to enhance the technical connotation of traditional Chinese medicines. The pilot workshop has passed GMP certification and acceptance and has become an incubator for the company's R&D and industrialization of new products.

The company has 1 national protected traditional Chinese medicine variety, 8 new drug certificates, 5 varieties under research, 2 Nanjing high-tech products, 2 independent innovative products, and 19 patent authorizations, including 15 invention patents, 4 design patents, and has successively undertaken the National 863 Project, the National New Drug Fund Project, the National Torch Program Project, Jiangsu Province and Nanjing City Science and Technology Projects, etc.

The trademark "Mochou" won the title of Nanjing Famous Trademark, and the Xuanqitongbi Capsule and its preparation process patent won the top ten outstanding patents in Nanjing and the first prize of Yuhua District Science and Technology Progress Award. At the same time, the company attaches great importance to the integration of industry, academia and research, and has successively become a master's training site of Yanbian University and an internship base of Nanjing Normal University, and has trained 9 graduate students and more than 20 undergraduates.

Product Series

The company’s main products include five series, including Huoxue Zhitong Capsules, Ciprofloxacin Hydrochloride Capsules, Qiju Dihuang Capsules, Qiju Dihuang Tablets, and Motherwort Granules. Included in the National Essential Drugs List.

1. Treatment of bruises, soft tissue injuries, muscle pain, rheumatism and rheumatoid with Huoxue Zhitong Capsules, Xuanqitongbi Capsules, Compound Chlorzoxazone Tablets, and Tripterygium wilfordii Total Terpene Tablets. 2. Treat gastric digestion and atrophic gastritis with pre-cancer lesions of the stomach, mainly Zhizhu Granules, Baobaole, and Renshu Jianwei Granules; treat enteritis mainly with Xinqingning Gastrointestinal medication;

3. Obstetrics and gynecology medications mainly including Ruquan Granules, Motherwort Granules, and Qinglin Granules;

4. Liuwei Dihuang Concentrated Capsules, Yishenling Granules Mainly immune-enhancing drugs;

5. Drugs mainly used to treat common diseases and frequently-occurring diseases, including Xiaobuihu Granules, Fuchu Granules, Xiaoerganmaoshu Granules, and Qianbai Rhinitis Tablets.

Marketing

The company has established a nationwide sales network, established offices in more than 20 provinces and cities including Beijing, Shanghai, Jiangsu, etc., and communicates with many domestic and foreign commercial customers. Maintain good business relationships with end customers. More than 20 Chinese and Western medicines, including orthopedics, gastroenterology, and gynecology, are sold throughout the country.

In the course of many years of business development, the company has summarized its unique management experience and marketing model based on the characteristics and actual situation of the development of the pharmaceutical market. "Reputation first, quality first, market first, service first" is the business purpose that our company has always pursued. With the business principle of "ensuring the best interests of customers and striving for the best benefits", our sales network covers the whole country. The volume has doubled year after year, and we have fully achieved a win-win situation with many distribution partners.

Under the new situation, the company will, as always, adhere to the corporate philosophy of "innovation, people-oriented, integrity, and win-win" and the business philosophy of "caring for health, protecting life" and be market-oriented. , create high-quality products, fully rely on a high-quality workforce, work together and work hard, strive to become a first-class pharmaceutical company, and serve society and patients with high-quality drugs.

Legal representative: Cheng Jun

Date of establishment: 1992-12-28

Registered capital: RMB 97.1431 million

Region : Jiangsu Province

Unified Social Credit Code: 913201921349315802

Business status: In business

Industry: Manufacturing

Company type: Limited liability company

English name: Nanjing Zhongshan Pharmaceutical Co., Ltd.

Staff size: 100-499 people

Company address: Nanjing Economic and Technological Development No. 21, Hengfa Road, District

Business scope: production and sales of tablets, capsules, and granules; extraction of traditional Chinese medicine. Medical technology development, transfer, consultation, and services; research, development, production, and sales of health foods, disinfectants, cosmetics, and arts and crafts. (Projects that require approval according to law can only be carried out with approval from relevant departments)